The Global Antimicrobial Susceptibility Test market accounted for $2.79 billion in 2019 and is expected to reach $4.98 billion by 2027 growing at a CAGR of 7.5% during the forecast period.
The rising prevalence of infectious diseases and the emergence of multidrug resistance due to drug abuse are the major factors propelling market growth.
However, high cost and unfavourable reimbursement scenario are hampering market growth.
Antimicrobial susceptibility testing is a procedure, which is used to determine for a specific organism or group of organisms that are susceptible to an antibiotic.
To examine the antimicrobial susceptibility, the most widely used testing methods are broth microdilution or rapid automated instrument methods.
These methods are commercially used and marketed with materials and devices.
Antimicrobial resistance is developed due to inaccurate diagnosis of infectious disease, lack of effective treatment guidelines, and non-adherence to the treatment regime.
Primary healthcare centres of both developed and developing nations are teeming grounds for superbug infection.
Microbiologists are working diligently to understand the disease etiology about the antimicrobial confrontation and develop broad-spectrum antibiotics to treat microbial infections.
Based on the application, the clinical diagnostics segment is going to have a lucrative growth during the forecast period owing to factors such as the rising burden of antimicrobial resistance, the increasing prevalence of infectious diseases, and growing awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications.
These are the factors that are responsible for the large market share of this application segment.
By geography, North America is going to have a lucrative growth during the forecast period due to the easy accessibility and better adoption of technologically advanced susceptibility testing methods and products.
The rising prevalence of antimicrobial resistance in North America is another key factor supporting the expansion of this regional segment in the global antimicrobial susceptibility testing market.
Some of the key players profiled in the Antimicrobial Susceptibility Test Market include Accelerate, Alifax Holding S.p.A., Beckman Coulter, Becton, Dickinson and Company, Bioanalyse, Bio-Rad Laboratories, Biotron Healthcare, Conda, Creative Diagnostics, Danaher Corporation (Cepheid), HiMedia Laboratories, Liofilchem, Merck, Merlin, Synbiosis, Thermo, and Fisher Scientific.
For more information, visit www.researchandmarkets.com